Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexibuprofen versus ibuprofen for fever relief in children aged 6 months to 3 years with respiratory tract infection
ChiCTR2400093489Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexibuprofen and ibuprofen in fever and Airways Infection (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Difference in temperature change after 4 hours of administration. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexibuprofenibuprofen
03
Conditions
feverAirways Infection
Beyond the preview
Go deeper on ChiCTR2400093489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093489.